The effects of canagliflozin compared to sitagliptin on cardiorespiratory fitness in type 2 diabetes mellitus and heart failure with reduced ejection fraction: The CANA-HF study. uri icon

authors

  • Carbone, Salvatore
  • Cooke, Richard
  • Rao, Krishnasree
  • B Shah, Keyur
  • Medina de Chazal, Horacio
  • Chiabrando, Juan Guido
  • Vecchié, Alessandra
  • Dell, Megan
  • L Mihalick, Virginia
  • Bogaev, Roberta
  • Hart, Linda
  • Hayley Billingsley, PhD, RD, CEP
  • Van Tassell, Benjamin W
  • Arena, Ross
  • Celi, Francesco S
  • Abbate, Antonio
  • Canada, Justin M
  • Bressi, Edoardo
  • Rotelli, Brando
  • Kadariya, Dinesh
  • Dixon, Dave L
  • Markley, Roshanak
  • Trankle, Cory R

publication date

  • January 1, 2020